ZNF322A_lung cancer_iTRAQ_LC-MSMS

ABSTRACT: ZNF322A, a transcription factor, has been identified as a novel putative oncogene in lung cancer. There are over 50% of amplification rates in both Asia and Caucasian lung cancer patients. This study is to use proteomics approach to establish the protein interaction network of ZNF322A.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Lung Adenocarcinoma

SUBMITTER: Li-Ling Lin  

LAB HEAD: Hsueh-Fen Juan

PROVIDER: PXD001123 | Pride | 2016-07-07

REPOSITORIES: Pride